← Back to Search

Brain Stimulation for PTSD

N/A
Recruiting
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability and willingness to perform procedures
Meet diagnostic criteria for past-month probable IPV-related PTSD.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This trial will study if a brain stimulation treatment (tDCS) can help adult women with a history of trauma and PTSD.

Who is the study for?
This trial is for adult female students aged 18-55 at a large southern university who have experienced intimate partner violence (IPV) and likely have PTSD. They must be able to give informed consent, perform required tasks, and either not be on medication or on stable medication for at least four weeks.Check my eligibility
What is being tested?
The study tests the effects of tDCS—a non-invasive brain stimulation technique—on inhibitory control in participants with probable PTSD from IPV. Participants will do tasks before and after receiving either real or sham tDCS, with their performance compared to see if there's any improvement.See study design
What are the potential side effects?
tDCS is generally considered safe but can cause mild side effects such as itching, tingling, or discomfort at the electrode site. Headache and fatigue may also occur after treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am willing and able to follow through with required medical procedures.
Select...
I have PTSD related to past intimate partner violence.
Select...
I am female.
Select...
I am between 18 and 55 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart Rate (HR)
Skin conductance level (SCL)
Stop Signal Reaction Time (SSRT)

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active tDCSActive Control1 Intervention
Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period and a constant current will be delivered for the 15-minutes between ramping
Group II: Shame tDCSPlacebo Group1 Intervention
Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period during which no stimulation will be delivered.

Find a Location

Who is running the clinical trial?

University of KentuckyLead Sponsor
187 Previous Clinical Trials
226,864 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I be included in this research project?

"To be eligible for this research, subjects must have been diagnosed with PTSD and possess an age between the limits of 18 to 55. Currently, the study is open to a maximum of 100 patients."

Answered by AI

Does this clinical investigation accommodate individuals over the age of thirty-five?

"This experiment has been designed to recruit individuals aged between 18 and 55. In comparison, there are 39 clinical trials targeting minors while 330 focus on seniors over 65 years old."

Answered by AI

How many volunteers are being accepted to join this clinical trial?

"Yes, the clinicaltrials.gov database confirms that this study is currently enrolling participants. This research project was first advertised on October 27th 2023 and has recently been updated November 6th 2023. 100 individuals are being recruited from 1 location for participation in this trial."

Answered by AI

Are there still vacancies available for participants in this experiment?

"Affirmative. The clinicaltrials.gov archives validate that this investigation is actively recruiting individuals, the first posting having been on October 27th 2023 and the last update occurring on November 6th of the same year. This study requires 100 participants from one centre to participate in it."

Answered by AI

Who else is applying?

What site did they apply to?
University of Kentucky
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
tDCS and Inhibitory Control in PTSD
Thomas Adams 2023. "tDCS and Inhibitory Control in PTSD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06100731.
All > Ptsd Cincinnati > Tdcs
~54 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top